nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—CYP2D6—breast cancer	0.0767	0.389	CbGaD
Trimipramine—CYP3A4—breast cancer	0.0658	0.334	CbGaD
Trimipramine—ABCB1—breast cancer	0.0548	0.278	CbGaD
Trimipramine—Dextropropoxyphene—Toremifene—breast cancer	0.0417	0.12	CrCrCtD
Trimipramine—Clofedanol—Toremifene—breast cancer	0.0302	0.0869	CrCrCtD
Trimipramine—Cyclobenzaprine—Tamoxifen—breast cancer	0.03	0.0865	CrCrCtD
Trimipramine—Orphenadrine—Toremifene—breast cancer	0.0292	0.0841	CrCrCtD
Trimipramine—Benzphetamine—Toremifene—breast cancer	0.0292	0.0841	CrCrCtD
Trimipramine—Dextropropoxyphene—Tamoxifen—breast cancer	0.0262	0.0755	CrCrCtD
Trimipramine—Diphenhydramine—Toremifene—breast cancer	0.0259	0.0747	CrCrCtD
Trimipramine—Dimetacrine—Tamoxifen—breast cancer	0.0233	0.0672	CrCrCtD
Trimipramine—Methadone—Tamoxifen—breast cancer	0.0219	0.0631	CrCrCtD
Trimipramine—Clofedanol—Tamoxifen—breast cancer	0.0189	0.0546	CrCrCtD
Trimipramine—Orphenadrine—Tamoxifen—breast cancer	0.0183	0.0528	CrCrCtD
Trimipramine—Benzphetamine—Tamoxifen—breast cancer	0.0183	0.0528	CrCrCtD
Trimipramine—Promazine—Tamoxifen—breast cancer	0.0175	0.0504	CrCrCtD
Trimipramine—CYP2C9—Anastrozole—breast cancer	0.0173	0.0639	CbGbCtD
Trimipramine—Diphenhydramine—Tamoxifen—breast cancer	0.0163	0.0469	CrCrCtD
Trimipramine—ABCB1—Toremifene—breast cancer	0.0154	0.0567	CbGbCtD
Trimipramine—CYP2C19—Lapatinib—breast cancer	0.0139	0.0513	CbGbCtD
Trimipramine—CYP3A4—Exemestane—breast cancer	0.0133	0.049	CbGbCtD
Trimipramine—CYP2C9—Idarubicin—breast cancer	0.0131	0.0484	CbGbCtD
Trimipramine—CYP2D6—Idarubicin—breast cancer	0.012	0.0443	CbGbCtD
Trimipramine—CYP3A4—Letrozole—breast cancer	0.0113	0.0417	CbGbCtD
Trimipramine—ABCB1—Lapatinib—breast cancer	0.0112	0.0414	CbGbCtD
Trimipramine—CYP3A4—Anastrozole—breast cancer	0.0101	0.0371	CbGbCtD
Trimipramine—CYP3A4—Toremifene—breast cancer	0.0092	0.034	CbGbCtD
Trimipramine—CYP3A4—Fulvestrant—breast cancer	0.00856	0.0316	CbGbCtD
Trimipramine—CYP3A4—Thiotepa—breast cancer	0.00763	0.0281	CbGbCtD
Trimipramine—CYP2C9—Capecitabine—breast cancer	0.00719	0.0265	CbGbCtD
Trimipramine—CYP3A4—Ixabepilone—breast cancer	0.00698	0.0257	CbGbCtD
Trimipramine—CYP2C19—Tamoxifen—breast cancer	0.00695	0.0257	CbGbCtD
Trimipramine—CYP3A4—Lapatinib—breast cancer	0.00671	0.0248	CbGbCtD
Trimipramine—ABCB1—Vinorelbine—breast cancer	0.00622	0.0229	CbGbCtD
Trimipramine—CYP2D6—Vinorelbine—breast cancer	0.00586	0.0216	CbGbCtD
Trimipramine—CYP2C9—Tamoxifen—breast cancer	0.00578	0.0213	CbGbCtD
Trimipramine—ABCB1—Tamoxifen—breast cancer	0.00561	0.0207	CbGbCtD
Trimipramine—ABCB1—Mitoxantrone—breast cancer	0.00547	0.0202	CbGbCtD
Trimipramine—CYP2D6—Tamoxifen—breast cancer	0.00529	0.0195	CbGbCtD
Trimipramine—CYP3A4—Raloxifene—breast cancer	0.00509	0.0188	CbGbCtD
Trimipramine—ABCB1—Gemcitabine—breast cancer	0.00483	0.0178	CbGbCtD
Trimipramine—CYP2C9—Paclitaxel—breast cancer	0.0045	0.0166	CbGbCtD
Trimipramine—ABCB1—Paclitaxel—breast cancer	0.00437	0.0161	CbGbCtD
Trimipramine—ABCB1—Irinotecan—breast cancer	0.00431	0.0159	CbGbCtD
Trimipramine—CYP2C9—Fluorouracil—breast cancer	0.00426	0.0157	CbGbCtD
Trimipramine—ABCB1—Vinblastine—breast cancer	0.00383	0.0141	CbGbCtD
Trimipramine—CYP3A4—Vinorelbine—breast cancer	0.00372	0.0137	CbGbCtD
Trimipramine—CYP2D6—Vinblastine—breast cancer	0.00361	0.0133	CbGbCtD
Trimipramine—CYP3A4—Tamoxifen—breast cancer	0.00336	0.0124	CbGbCtD
Trimipramine—CYP3A4—Mitoxantrone—breast cancer	0.00328	0.0121	CbGbCtD
Trimipramine—ABCB1—Docetaxel—breast cancer	0.00316	0.0117	CbGbCtD
Trimipramine—CYP3A4—Paclitaxel—breast cancer	0.00262	0.00966	CbGbCtD
Trimipramine—CYP3A4—Irinotecan—breast cancer	0.00258	0.00953	CbGbCtD
Trimipramine—ABCB1—Doxorubicin—breast cancer	0.00235	0.00869	CbGbCtD
Trimipramine—CYP3A4—Vinblastine—breast cancer	0.0023	0.00847	CbGbCtD
Trimipramine—ABCB1—Methotrexate—breast cancer	0.00228	0.00842	CbGbCtD
Trimipramine—CYP2D6—Doxorubicin—breast cancer	0.00222	0.00819	CbGbCtD
Trimipramine—CYP3A4—Docetaxel—breast cancer	0.00189	0.00698	CbGbCtD
Trimipramine—CYP3A4—Doxorubicin—breast cancer	0.00141	0.00521	CbGbCtD
Trimipramine—Dimetacrine—ACHE—breast cancer	0.000297	0.115	CrCbGaD
Trimipramine—Benazepril—MTHFR—breast cancer	0.000168	0.0653	CrCbGaD
Trimipramine—Ethopropazine—BCHE—breast cancer	0.000104	0.0403	CrCbGaD
Trimipramine—CYP2C9—mammary gland—breast cancer	9.46e-05	0.0384	CbGeAlD
Trimipramine—Orphenadrine—SCN10A—breast cancer	9.12e-05	0.0354	CrCbGaD
Trimipramine—Clomipramine—GSTP1—breast cancer	8.71e-05	0.0338	CrCbGaD
Trimipramine—HRH1—nipple—breast cancer	7.72e-05	0.0313	CbGeAlD
Trimipramine—ADRA2A—nipple—breast cancer	7.58e-05	0.0308	CbGeAlD
Trimipramine—Aprindine—CYP2D6—breast cancer	7.34e-05	0.0285	CrCbGaD
Trimipramine—ADRA1A—epithelium—breast cancer	6.71e-05	0.0273	CbGeAlD
Trimipramine—HTR1D—female reproductive system—breast cancer	6.49e-05	0.0264	CbGeAlD
Trimipramine—HTR2C—female reproductive system—breast cancer	6.43e-05	0.0261	CbGeAlD
Trimipramine—Cyclobenzaprine—CYP2D6—breast cancer	6.25e-05	0.0242	CrCbGaD
Trimipramine—Epinastine—CYP2D6—breast cancer	6.2e-05	0.0241	CrCbGaD
Trimipramine—SLC6A4—female reproductive system—breast cancer	6.09e-05	0.0247	CbGeAlD
Trimipramine—Mequitazine—CYP2D6—breast cancer	5.83e-05	0.0226	CrCbGaD
Trimipramine—Alimemazine—CYP3A4—breast cancer	5.81e-05	0.0226	CrCbGaD
Trimipramine—Pollakiuria—Epirubicin—breast cancer	5.66e-05	0.000506	CcSEcCtD
Trimipramine—Body temperature increased—Fluorouracil—breast cancer	5.65e-05	0.000505	CcSEcCtD
Trimipramine—Eosinophilia—Doxorubicin—breast cancer	5.61e-05	0.000501	CcSEcCtD
Trimipramine—Palpitations—Docetaxel—breast cancer	5.59e-05	0.0005	CcSEcCtD
Trimipramine—Weight increased—Epirubicin—breast cancer	5.57e-05	0.000498	CcSEcCtD
Trimipramine—Malaise—Capecitabine—breast cancer	5.52e-05	0.000494	CcSEcCtD
Trimipramine—Insomnia—Paclitaxel—breast cancer	5.51e-05	0.000492	CcSEcCtD
Trimipramine—Vomiting—Thiotepa—breast cancer	5.5e-05	0.000491	CcSEcCtD
Trimipramine—Convulsion—Docetaxel—breast cancer	5.48e-05	0.00049	CcSEcCtD
Trimipramine—Paraesthesia—Paclitaxel—breast cancer	5.47e-05	0.000489	CcSEcCtD
Trimipramine—Hypertension—Docetaxel—breast cancer	5.46e-05	0.000488	CcSEcCtD
Trimipramine—Drowsiness—Epirubicin—breast cancer	5.46e-05	0.000488	CcSEcCtD
Trimipramine—Rash—Thiotepa—breast cancer	5.45e-05	0.000487	CcSEcCtD
Trimipramine—Dermatitis—Thiotepa—breast cancer	5.45e-05	0.000487	CcSEcCtD
Trimipramine—Agranulocytosis—Methotrexate—breast cancer	5.44e-05	0.000487	CcSEcCtD
Trimipramine—ADRA1A—adipose tissue—breast cancer	5.43e-05	0.022	CbGeAlD
Trimipramine—Headache—Thiotepa—breast cancer	5.42e-05	0.000484	CcSEcCtD
Trimipramine—Somnolence—Paclitaxel—breast cancer	5.41e-05	0.000484	CcSEcCtD
Trimipramine—Palpitations—Capecitabine—breast cancer	5.41e-05	0.000484	CcSEcCtD
Trimipramine—Pancytopenia—Doxorubicin—breast cancer	5.38e-05	0.000481	CcSEcCtD
Trimipramine—Nausea—Vinorelbine—breast cancer	5.38e-05	0.000481	CcSEcCtD
Trimipramine—SLC6A2—female reproductive system—breast cancer	5.36e-05	0.0218	CbGeAlD
Trimipramine—Dyspepsia—Paclitaxel—breast cancer	5.36e-05	0.000479	CcSEcCtD
Trimipramine—Asthenia—Irinotecan—breast cancer	5.36e-05	0.000479	CcSEcCtD
Trimipramine—Asthenia—Mitoxantrone—breast cancer	5.36e-05	0.000479	CcSEcCtD
Trimipramine—Cyclobenzaprine—CYP3A4—breast cancer	5.36e-05	0.0208	CrCbGaD
Trimipramine—Neuropathy peripheral—Epirubicin—breast cancer	5.35e-05	0.000478	CcSEcCtD
Trimipramine—DRD2—pituitary gland—breast cancer	5.34e-05	0.0217	CbGeAlD
Trimipramine—Stomatitis—Epirubicin—breast cancer	5.32e-05	0.000476	CcSEcCtD
Trimipramine—Jaundice—Epirubicin—breast cancer	5.32e-05	0.000476	CcSEcCtD
Trimipramine—HTR2A—embryo—breast cancer	5.32e-05	0.0216	CbGeAlD
Trimipramine—Epinastine—CYP3A4—breast cancer	5.32e-05	0.0206	CrCbGaD
Trimipramine—Decreased appetite—Paclitaxel—breast cancer	5.29e-05	0.000473	CcSEcCtD
Trimipramine—Hypertension—Capecitabine—breast cancer	5.29e-05	0.000473	CcSEcCtD
Trimipramine—HTR1A—adrenal gland—breast cancer	5.28e-05	0.0214	CbGeAlD
Trimipramine—Dry mouth—Docetaxel—breast cancer	5.27e-05	0.000471	CcSEcCtD
Trimipramine—Fatigue—Paclitaxel—breast cancer	5.25e-05	0.000469	CcSEcCtD
Trimipramine—SLC6A2—adrenal gland—breast cancer	5.24e-05	0.0213	CbGeAlD
Trimipramine—Pollakiuria—Doxorubicin—breast cancer	5.23e-05	0.000468	CcSEcCtD
Trimipramine—Methadone—CYP19A1—breast cancer	5.23e-05	0.0203	CrCbGaD
Trimipramine—Asthenia—Gemcitabine—breast cancer	5.22e-05	0.000467	CcSEcCtD
Trimipramine—Constipation—Paclitaxel—breast cancer	5.21e-05	0.000466	CcSEcCtD
Trimipramine—Confusional state—Docetaxel—breast cancer	5.2e-05	0.000465	CcSEcCtD
Trimipramine—HRH1—epithelium—breast cancer	5.2e-05	0.0211	CbGeAlD
Trimipramine—Anxiety—Capecitabine—breast cancer	5.2e-05	0.000464	CcSEcCtD
Trimipramine—Oedema—Docetaxel—breast cancer	5.16e-05	0.000461	CcSEcCtD
Trimipramine—SLC6A4—endocrine gland—breast cancer	5.16e-05	0.0209	CbGeAlD
Trimipramine—Weight increased—Doxorubicin—breast cancer	5.16e-05	0.000461	CcSEcCtD
Trimipramine—Discomfort—Capecitabine—breast cancer	5.15e-05	0.00046	CcSEcCtD
Trimipramine—Pruritus—Gemcitabine—breast cancer	5.15e-05	0.00046	CcSEcCtD
Trimipramine—Nausea—Thiotepa—breast cancer	5.14e-05	0.000459	CcSEcCtD
Trimipramine—Diarrhoea—Mitoxantrone—breast cancer	5.11e-05	0.000457	CcSEcCtD
Trimipramine—Diarrhoea—Irinotecan—breast cancer	5.11e-05	0.000457	CcSEcCtD
Trimipramine—Dry mouth—Capecitabine—breast cancer	5.1e-05	0.000456	CcSEcCtD
Trimipramine—Agranulocytosis—Epirubicin—breast cancer	5.09e-05	0.000455	CcSEcCtD
Trimipramine—Pruritus—Fluorouracil—breast cancer	5.06e-05	0.000452	CcSEcCtD
Trimipramine—Thrombocytopenia—Docetaxel—breast cancer	5.05e-05	0.000452	CcSEcCtD
Trimipramine—Drowsiness—Doxorubicin—breast cancer	5.05e-05	0.000452	CcSEcCtD
Trimipramine—Confusional state—Capecitabine—breast cancer	5.04e-05	0.00045	CcSEcCtD
Trimipramine—Tachycardia—Docetaxel—breast cancer	5.04e-05	0.00045	CcSEcCtD
Trimipramine—Feeling abnormal—Paclitaxel—breast cancer	5.02e-05	0.000449	CcSEcCtD
Trimipramine—Mequitazine—CYP3A4—breast cancer	5e-05	0.0194	CrCbGaD
Trimipramine—Oedema—Capecitabine—breast cancer	5e-05	0.000447	CcSEcCtD
Trimipramine—Diarrhoea—Gemcitabine—breast cancer	4.98e-05	0.000445	CcSEcCtD
Trimipramine—Neuropathy peripheral—Doxorubicin—breast cancer	4.95e-05	0.000443	CcSEcCtD
Trimipramine—Dizziness—Irinotecan—breast cancer	4.94e-05	0.000441	CcSEcCtD
Trimipramine—Stomatitis—Doxorubicin—breast cancer	4.92e-05	0.00044	CcSEcCtD
Trimipramine—Jaundice—Doxorubicin—breast cancer	4.92e-05	0.00044	CcSEcCtD
Trimipramine—Anorexia—Docetaxel—breast cancer	4.92e-05	0.00044	CcSEcCtD
Trimipramine—Oxcarbazepine—CYP3A4—breast cancer	4.9e-05	0.019	CrCbGaD
Trimipramine—Diarrhoea—Fluorouracil—breast cancer	4.89e-05	0.000437	CcSEcCtD
Trimipramine—Thrombocytopenia—Capecitabine—breast cancer	4.89e-05	0.000437	CcSEcCtD
Trimipramine—Tinnitus—Methotrexate—breast cancer	4.88e-05	0.000436	CcSEcCtD
Trimipramine—Tachycardia—Capecitabine—breast cancer	4.88e-05	0.000436	CcSEcCtD
Trimipramine—Hypoaesthesia—Epirubicin—breast cancer	4.88e-05	0.000436	CcSEcCtD
Trimipramine—ADRA1A—adrenal gland—breast cancer	4.87e-05	0.0198	CbGeAlD
Trimipramine—Urticaria—Paclitaxel—breast cancer	4.84e-05	0.000432	CcSEcCtD
Trimipramine—Hypotension—Docetaxel—breast cancer	4.82e-05	0.000431	CcSEcCtD
Trimipramine—Abdominal pain—Paclitaxel—breast cancer	4.81e-05	0.00043	CcSEcCtD
Trimipramine—Body temperature increased—Paclitaxel—breast cancer	4.81e-05	0.00043	CcSEcCtD
Trimipramine—Anorexia—Capecitabine—breast cancer	4.76e-05	0.000426	CcSEcCtD
Trimipramine—Vomiting—Irinotecan—breast cancer	4.75e-05	0.000424	CcSEcCtD
Trimipramine—Vomiting—Mitoxantrone—breast cancer	4.75e-05	0.000424	CcSEcCtD
Trimipramine—Dizziness—Fluorouracil—breast cancer	4.73e-05	0.000423	CcSEcCtD
Trimipramine—Agranulocytosis—Doxorubicin—breast cancer	4.71e-05	0.000421	CcSEcCtD
Trimipramine—Nortriptyline—PTGS1—breast cancer	4.71e-05	0.0183	CrCbGaD
Trimipramine—Rash—Irinotecan—breast cancer	4.71e-05	0.000421	CcSEcCtD
Trimipramine—Rash—Mitoxantrone—breast cancer	4.71e-05	0.000421	CcSEcCtD
Trimipramine—Dermatitis—Mitoxantrone—breast cancer	4.7e-05	0.00042	CcSEcCtD
Trimipramine—Dermatitis—Irinotecan—breast cancer	4.7e-05	0.00042	CcSEcCtD
Trimipramine—Headache—Irinotecan—breast cancer	4.68e-05	0.000418	CcSEcCtD
Trimipramine—Headache—Mitoxantrone—breast cancer	4.68e-05	0.000418	CcSEcCtD
Trimipramine—Hypotension—Capecitabine—breast cancer	4.67e-05	0.000417	CcSEcCtD
Trimipramine—Insomnia—Docetaxel—breast cancer	4.67e-05	0.000417	CcSEcCtD
Trimipramine—HRH1—endometrium—breast cancer	4.66e-05	0.0189	CbGeAlD
Trimipramine—Paraesthesia—Docetaxel—breast cancer	4.63e-05	0.000414	CcSEcCtD
Trimipramine—Alopecia—Methotrexate—breast cancer	4.63e-05	0.000414	CcSEcCtD
Trimipramine—Vomiting—Gemcitabine—breast cancer	4.62e-05	0.000413	CcSEcCtD
Trimipramine—Somnolence—Docetaxel—breast cancer	4.59e-05	0.00041	CcSEcCtD
Trimipramine—Rash—Gemcitabine—breast cancer	4.59e-05	0.00041	CcSEcCtD
Trimipramine—Dermatitis—Gemcitabine—breast cancer	4.58e-05	0.00041	CcSEcCtD
Trimipramine—HTR1A—endocrine gland—breast cancer	4.58e-05	0.0186	CbGeAlD
Trimipramine—ADRA2A—endometrium—breast cancer	4.58e-05	0.0186	CbGeAlD
Trimipramine—Tinnitus—Epirubicin—breast cancer	4.57e-05	0.000408	CcSEcCtD
Trimipramine—Headache—Gemcitabine—breast cancer	4.56e-05	0.000407	CcSEcCtD
Trimipramine—Flushing—Epirubicin—breast cancer	4.55e-05	0.000407	CcSEcCtD
Trimipramine—Vomiting—Fluorouracil—breast cancer	4.55e-05	0.000406	CcSEcCtD
Trimipramine—Dyspepsia—Docetaxel—breast cancer	4.54e-05	0.000406	CcSEcCtD
Trimipramine—SLC6A2—endocrine gland—breast cancer	4.54e-05	0.0184	CbGeAlD
Trimipramine—Insomnia—Capecitabine—breast cancer	4.52e-05	0.000404	CcSEcCtD
Trimipramine—Hypoaesthesia—Doxorubicin—breast cancer	4.51e-05	0.000403	CcSEcCtD
Trimipramine—Rash—Fluorouracil—breast cancer	4.51e-05	0.000403	CcSEcCtD
Trimipramine—Dermatitis—Fluorouracil—breast cancer	4.51e-05	0.000403	CcSEcCtD
Trimipramine—Paraesthesia—Capecitabine—breast cancer	4.49e-05	0.000401	CcSEcCtD
Trimipramine—Decreased appetite—Docetaxel—breast cancer	4.49e-05	0.000401	CcSEcCtD
Trimipramine—Headache—Fluorouracil—breast cancer	4.48e-05	0.0004	CcSEcCtD
Trimipramine—Dysgeusia—Methotrexate—breast cancer	4.46e-05	0.000399	CcSEcCtD
Trimipramine—Fatigue—Docetaxel—breast cancer	4.45e-05	0.000398	CcSEcCtD
Trimipramine—Nausea—Mitoxantrone—breast cancer	4.44e-05	0.000396	CcSEcCtD
Trimipramine—Nausea—Irinotecan—breast cancer	4.44e-05	0.000396	CcSEcCtD
Trimipramine—Epinastine—ABCB1—breast cancer	4.43e-05	0.0172	CrCbGaD
Trimipramine—Constipation—Docetaxel—breast cancer	4.41e-05	0.000395	CcSEcCtD
Trimipramine—Dyspepsia—Capecitabine—breast cancer	4.4e-05	0.000393	CcSEcCtD
Trimipramine—Arrhythmia—Epirubicin—breast cancer	4.38e-05	0.000391	CcSEcCtD
Trimipramine—Asthenia—Paclitaxel—breast cancer	4.37e-05	0.000391	CcSEcCtD
Trimipramine—Diphenhydramine—PTGS1—breast cancer	4.35e-05	0.0169	CrCbGaD
Trimipramine—Decreased appetite—Capecitabine—breast cancer	4.34e-05	0.000388	CcSEcCtD
Trimipramine—HTR2A—epithelium—breast cancer	4.34e-05	0.0176	CbGeAlD
Trimipramine—Alopecia—Epirubicin—breast cancer	4.33e-05	0.000387	CcSEcCtD
Trimipramine—Nausea—Gemcitabine—breast cancer	4.32e-05	0.000386	CcSEcCtD
Trimipramine—Fatigue—Capecitabine—breast cancer	4.31e-05	0.000385	CcSEcCtD
Trimipramine—Pruritus—Paclitaxel—breast cancer	4.31e-05	0.000385	CcSEcCtD
Trimipramine—Vision blurred—Methotrexate—breast cancer	4.3e-05	0.000384	CcSEcCtD
Trimipramine—Oxcarbazepine—ALB—breast cancer	4.27e-05	0.0166	CrCbGaD
Trimipramine—Constipation—Capecitabine—breast cancer	4.27e-05	0.000382	CcSEcCtD
Trimipramine—CYP2C19—endocrine gland—breast cancer	4.27e-05	0.0174	CbGeAlD
Trimipramine—Feeling abnormal—Docetaxel—breast cancer	4.25e-05	0.00038	CcSEcCtD
Trimipramine—Nausea—Fluorouracil—breast cancer	4.25e-05	0.00038	CcSEcCtD
Trimipramine—Ill-defined disorder—Methotrexate—breast cancer	4.23e-05	0.000378	CcSEcCtD
Trimipramine—Tinnitus—Doxorubicin—breast cancer	4.23e-05	0.000378	CcSEcCtD
Trimipramine—ADRA1A—endocrine gland—breast cancer	4.22e-05	0.0171	CbGeAlD
Trimipramine—Dextropropoxyphene—CYP2D6—breast cancer	4.22e-05	0.0164	CrCbGaD
Trimipramine—ADRA2A—uterus—breast cancer	4.22e-05	0.0171	CbGeAlD
Trimipramine—Flushing—Doxorubicin—breast cancer	4.21e-05	0.000376	CcSEcCtD
Trimipramine—HRH1—adipose tissue—breast cancer	4.2e-05	0.0171	CbGeAlD
Trimipramine—Dysgeusia—Epirubicin—breast cancer	4.18e-05	0.000373	CcSEcCtD
Trimipramine—Diarrhoea—Paclitaxel—breast cancer	4.17e-05	0.000372	CcSEcCtD
Trimipramine—ADRA2A—pituitary gland—breast cancer	4.14e-05	0.0168	CbGeAlD
Trimipramine—DRD2—endocrine gland—breast cancer	4.14e-05	0.0168	CbGeAlD
Trimipramine—ADRA2A—adipose tissue—breast cancer	4.13e-05	0.0168	CbGeAlD
Trimipramine—Feeling abnormal—Capecitabine—breast cancer	4.12e-05	0.000368	CcSEcCtD
Trimipramine—Malaise—Methotrexate—breast cancer	4.11e-05	0.000367	CcSEcCtD
Trimipramine—Chlorpromazine—BCHE—breast cancer	4.1e-05	0.0159	CrCbGaD
Trimipramine—Body temperature increased—Docetaxel—breast cancer	4.08e-05	0.000365	CcSEcCtD
Trimipramine—Abdominal pain—Docetaxel—breast cancer	4.08e-05	0.000365	CcSEcCtD
Trimipramine—Arrhythmia—Doxorubicin—breast cancer	4.05e-05	0.000362	CcSEcCtD
Trimipramine—Dizziness—Paclitaxel—breast cancer	4.03e-05	0.00036	CcSEcCtD
Trimipramine—Vision blurred—Epirubicin—breast cancer	4.02e-05	0.000359	CcSEcCtD
Trimipramine—Alopecia—Doxorubicin—breast cancer	4.01e-05	0.000358	CcSEcCtD
Trimipramine—Urticaria—Capecitabine—breast cancer	3.97e-05	0.000355	CcSEcCtD
Trimipramine—Ill-defined disorder—Epirubicin—breast cancer	3.96e-05	0.000354	CcSEcCtD
Trimipramine—Body temperature increased—Capecitabine—breast cancer	3.95e-05	0.000353	CcSEcCtD
Trimipramine—Abdominal pain—Capecitabine—breast cancer	3.95e-05	0.000353	CcSEcCtD
Trimipramine—Convulsion—Methotrexate—breast cancer	3.95e-05	0.000353	CcSEcCtD
Trimipramine—Agitation—Epirubicin—breast cancer	3.92e-05	0.00035	CcSEcCtD
Trimipramine—CYP2C9—female reproductive system—breast cancer	3.91e-05	0.0159	CbGeAlD
Trimipramine—Vomiting—Paclitaxel—breast cancer	3.87e-05	0.000346	CcSEcCtD
Trimipramine—Dysgeusia—Doxorubicin—breast cancer	3.87e-05	0.000346	CcSEcCtD
Trimipramine—HRH1—female reproductive system—breast cancer	3.86e-05	0.0157	CbGeAlD
Trimipramine—Malaise—Epirubicin—breast cancer	3.85e-05	0.000344	CcSEcCtD
Trimipramine—Rash—Paclitaxel—breast cancer	3.84e-05	0.000343	CcSEcCtD
Trimipramine—Dermatitis—Paclitaxel—breast cancer	3.84e-05	0.000343	CcSEcCtD
Trimipramine—Discomfort—Methotrexate—breast cancer	3.83e-05	0.000343	CcSEcCtD
Trimipramine—Headache—Paclitaxel—breast cancer	3.82e-05	0.000341	CcSEcCtD
Trimipramine—ADRA2A—female reproductive system—breast cancer	3.79e-05	0.0154	CbGeAlD
Trimipramine—Palpitations—Epirubicin—breast cancer	3.77e-05	0.000337	CcSEcCtD
Trimipramine—HRH1—adrenal gland—breast cancer	3.77e-05	0.0153	CbGeAlD
Trimipramine—Confusional state—Methotrexate—breast cancer	3.75e-05	0.000335	CcSEcCtD
Trimipramine—Vision blurred—Doxorubicin—breast cancer	3.72e-05	0.000333	CcSEcCtD
Trimipramine—Asthenia—Docetaxel—breast cancer	3.7e-05	0.000331	CcSEcCtD
Trimipramine—ADRA2A—adrenal gland—breast cancer	3.7e-05	0.015	CbGeAlD
Trimipramine—Convulsion—Epirubicin—breast cancer	3.7e-05	0.00033	CcSEcCtD
Trimipramine—Hypertension—Epirubicin—breast cancer	3.68e-05	0.000329	CcSEcCtD
Trimipramine—Ill-defined disorder—Doxorubicin—breast cancer	3.66e-05	0.000327	CcSEcCtD
Trimipramine—Pruritus—Docetaxel—breast cancer	3.65e-05	0.000326	CcSEcCtD
Trimipramine—Thrombocytopenia—Methotrexate—breast cancer	3.64e-05	0.000326	CcSEcCtD
Trimipramine—Agitation—Doxorubicin—breast cancer	3.63e-05	0.000324	CcSEcCtD
Trimipramine—Anxiety—Epirubicin—breast cancer	3.62e-05	0.000324	CcSEcCtD
Trimipramine—Dextropropoxyphene—CYP3A4—breast cancer	3.62e-05	0.014	CrCbGaD
Trimipramine—Nausea—Paclitaxel—breast cancer	3.62e-05	0.000323	CcSEcCtD
Trimipramine—Discomfort—Epirubicin—breast cancer	3.59e-05	0.000321	CcSEcCtD
Trimipramine—Mianserin—CYP2D6—breast cancer	3.59e-05	0.0139	CrCbGaD
Trimipramine—Asthenia—Capecitabine—breast cancer	3.59e-05	0.000321	CcSEcCtD
Trimipramine—Malaise—Doxorubicin—breast cancer	3.56e-05	0.000318	CcSEcCtD
Trimipramine—Dry mouth—Epirubicin—breast cancer	3.55e-05	0.000318	CcSEcCtD
Trimipramine—Anorexia—Methotrexate—breast cancer	3.55e-05	0.000317	CcSEcCtD
Trimipramine—Pruritus—Capecitabine—breast cancer	3.54e-05	0.000316	CcSEcCtD
Trimipramine—Diarrhoea—Docetaxel—breast cancer	3.53e-05	0.000316	CcSEcCtD
Trimipramine—HTR2A—pituitary gland—breast cancer	3.52e-05	0.0143	CbGeAlD
Trimipramine—HRH1—female gonad—breast cancer	3.51e-05	0.0143	CbGeAlD
Trimipramine—Confusional state—Epirubicin—breast cancer	3.51e-05	0.000314	CcSEcCtD
Trimipramine—Palpitations—Doxorubicin—breast cancer	3.49e-05	0.000312	CcSEcCtD
Trimipramine—ABCB1—embryo—breast cancer	3.49e-05	0.0142	CbGeAlD
Trimipramine—Oedema—Epirubicin—breast cancer	3.48e-05	0.000311	CcSEcCtD
Trimipramine—Hypotension—Methotrexate—breast cancer	3.48e-05	0.000311	CcSEcCtD
Trimipramine—ADRA2A—female gonad—breast cancer	3.45e-05	0.014	CbGeAlD
Trimipramine—Convulsion—Doxorubicin—breast cancer	3.42e-05	0.000306	CcSEcCtD
Trimipramine—Diarrhoea—Capecitabine—breast cancer	3.42e-05	0.000306	CcSEcCtD
Trimipramine—Dizziness—Docetaxel—breast cancer	3.41e-05	0.000305	CcSEcCtD
Trimipramine—Thrombocytopenia—Epirubicin—breast cancer	3.41e-05	0.000305	CcSEcCtD
Trimipramine—Hypertension—Doxorubicin—breast cancer	3.41e-05	0.000305	CcSEcCtD
Trimipramine—Tachycardia—Epirubicin—breast cancer	3.4e-05	0.000304	CcSEcCtD
Trimipramine—Insomnia—Methotrexate—breast cancer	3.36e-05	0.000301	CcSEcCtD
Trimipramine—Anxiety—Doxorubicin—breast cancer	3.35e-05	0.000299	CcSEcCtD
Trimipramine—Paraesthesia—Methotrexate—breast cancer	3.34e-05	0.000299	CcSEcCtD
Trimipramine—Carbamazepine—CYP3A4—breast cancer	3.34e-05	0.013	CrCbGaD
Trimipramine—Discomfort—Doxorubicin—breast cancer	3.32e-05	0.000297	CcSEcCtD
Trimipramine—Anorexia—Epirubicin—breast cancer	3.32e-05	0.000297	CcSEcCtD
Trimipramine—CYP2C9—endocrine gland—breast cancer	3.31e-05	0.0135	CbGeAlD
Trimipramine—Somnolence—Methotrexate—breast cancer	3.31e-05	0.000296	CcSEcCtD
Trimipramine—Dizziness—Capecitabine—breast cancer	3.3e-05	0.000295	CcSEcCtD
Trimipramine—Dry mouth—Doxorubicin—breast cancer	3.29e-05	0.000294	CcSEcCtD
Trimipramine—Vomiting—Docetaxel—breast cancer	3.28e-05	0.000293	CcSEcCtD
Trimipramine—Clomipramine—CYP2D6—breast cancer	3.28e-05	0.0127	CrCbGaD
Trimipramine—Dyspepsia—Methotrexate—breast cancer	3.27e-05	0.000293	CcSEcCtD
Trimipramine—HRH1—endocrine gland—breast cancer	3.27e-05	0.0133	CbGeAlD
Trimipramine—Rash—Docetaxel—breast cancer	3.25e-05	0.000291	CcSEcCtD
Trimipramine—Hypotension—Epirubicin—breast cancer	3.25e-05	0.000291	CcSEcCtD
Trimipramine—Dermatitis—Docetaxel—breast cancer	3.25e-05	0.000291	CcSEcCtD
Trimipramine—Confusional state—Doxorubicin—breast cancer	3.25e-05	0.00029	CcSEcCtD
Trimipramine—Decreased appetite—Methotrexate—breast cancer	3.23e-05	0.000289	CcSEcCtD
Trimipramine—Headache—Docetaxel—breast cancer	3.23e-05	0.000289	CcSEcCtD
Trimipramine—Acepromazine—ALB—breast cancer	3.23e-05	0.0125	CrCbGaD
Trimipramine—HTR2A—female reproductive system—breast cancer	3.22e-05	0.0131	CbGeAlD
Trimipramine—Oedema—Doxorubicin—breast cancer	3.22e-05	0.000288	CcSEcCtD
Trimipramine—ADRA2A—endocrine gland—breast cancer	3.21e-05	0.013	CbGeAlD
Trimipramine—Fatigue—Methotrexate—breast cancer	3.21e-05	0.000287	CcSEcCtD
Trimipramine—Nortriptyline—CYP2D6—breast cancer	3.21e-05	0.0124	CrCbGaD
Trimipramine—Vomiting—Capecitabine—breast cancer	3.18e-05	0.000284	CcSEcCtD
Trimipramine—Benzphetamine—CYP3A4—breast cancer	3.17e-05	0.0123	CrCbGaD
Trimipramine—Thrombocytopenia—Doxorubicin—breast cancer	3.15e-05	0.000282	CcSEcCtD
Trimipramine—Rash—Capecitabine—breast cancer	3.15e-05	0.000282	CcSEcCtD
Trimipramine—Insomnia—Epirubicin—breast cancer	3.15e-05	0.000281	CcSEcCtD
Trimipramine—Dermatitis—Capecitabine—breast cancer	3.15e-05	0.000281	CcSEcCtD
Trimipramine—HTR2A—adrenal gland—breast cancer	3.15e-05	0.0128	CbGeAlD
Trimipramine—Tachycardia—Doxorubicin—breast cancer	3.14e-05	0.000281	CcSEcCtD
Trimipramine—SLC6A2—lymph node—breast cancer	3.14e-05	0.0127	CbGeAlD
Trimipramine—Headache—Capecitabine—breast cancer	3.13e-05	0.00028	CcSEcCtD
Trimipramine—Paraesthesia—Epirubicin—breast cancer	3.13e-05	0.000279	CcSEcCtD
Trimipramine—Somnolence—Epirubicin—breast cancer	3.1e-05	0.000277	CcSEcCtD
Trimipramine—Mianserin—CYP3A4—breast cancer	3.08e-05	0.0119	CrCbGaD
Trimipramine—Anorexia—Doxorubicin—breast cancer	3.07e-05	0.000274	CcSEcCtD
Trimipramine—Nausea—Docetaxel—breast cancer	3.07e-05	0.000274	CcSEcCtD
Trimipramine—Feeling abnormal—Methotrexate—breast cancer	3.07e-05	0.000274	CcSEcCtD
Trimipramine—Dyspepsia—Epirubicin—breast cancer	3.06e-05	0.000274	CcSEcCtD
Trimipramine—Decreased appetite—Epirubicin—breast cancer	3.03e-05	0.000271	CcSEcCtD
Trimipramine—Hypotension—Doxorubicin—breast cancer	3.01e-05	0.000269	CcSEcCtD
Trimipramine—Fatigue—Epirubicin—breast cancer	3e-05	0.000268	CcSEcCtD
Trimipramine—CYP3A4—female reproductive system—breast cancer	2.99e-05	0.0121	CbGeAlD
Trimipramine—Constipation—Epirubicin—breast cancer	2.98e-05	0.000266	CcSEcCtD
Trimipramine—Nausea—Capecitabine—breast cancer	2.97e-05	0.000265	CcSEcCtD
Trimipramine—Diphenhydramine—CYP2D6—breast cancer	2.96e-05	0.0115	CrCbGaD
Trimipramine—Urticaria—Methotrexate—breast cancer	2.96e-05	0.000264	CcSEcCtD
Trimipramine—Methotrimeprazine—CYP2D6—breast cancer	2.95e-05	0.0114	CrCbGaD
Trimipramine—Body temperature increased—Methotrexate—breast cancer	2.94e-05	0.000263	CcSEcCtD
Trimipramine—Abdominal pain—Methotrexate—breast cancer	2.94e-05	0.000263	CcSEcCtD
Trimipramine—CYP2D6—female reproductive system—breast cancer	2.94e-05	0.0119	CbGeAlD
Trimipramine—Insomnia—Doxorubicin—breast cancer	2.91e-05	0.00026	CcSEcCtD
Trimipramine—Promethazine—CYP2D6—breast cancer	2.91e-05	0.0113	CrCbGaD
Trimipramine—Paraesthesia—Doxorubicin—breast cancer	2.89e-05	0.000259	CcSEcCtD
Trimipramine—Doxepin—CYP2D6—breast cancer	2.88e-05	0.0112	CrCbGaD
Trimipramine—Feeling abnormal—Epirubicin—breast cancer	2.87e-05	0.000256	CcSEcCtD
Trimipramine—Somnolence—Doxorubicin—breast cancer	2.86e-05	0.000256	CcSEcCtD
Trimipramine—Methadone—CYP2D6—breast cancer	2.86e-05	0.0111	CrCbGaD
Trimipramine—ABCB1—epithelium—breast cancer	2.84e-05	0.0116	CbGeAlD
Trimipramine—Dyspepsia—Doxorubicin—breast cancer	2.84e-05	0.000253	CcSEcCtD
Trimipramine—Clomipramine—CYP3A4—breast cancer	2.81e-05	0.0109	CrCbGaD
Trimipramine—Decreased appetite—Doxorubicin—breast cancer	2.8e-05	0.00025	CcSEcCtD
Trimipramine—Carbamazepine—ABCB1—breast cancer	2.78e-05	0.0108	CrCbGaD
Trimipramine—Fatigue—Doxorubicin—breast cancer	2.78e-05	0.000248	CcSEcCtD
Trimipramine—Urticaria—Epirubicin—breast cancer	2.77e-05	0.000247	CcSEcCtD
Trimipramine—Constipation—Doxorubicin—breast cancer	2.75e-05	0.000246	CcSEcCtD
Trimipramine—Abdominal pain—Epirubicin—breast cancer	2.75e-05	0.000246	CcSEcCtD
Trimipramine—Body temperature increased—Epirubicin—breast cancer	2.75e-05	0.000246	CcSEcCtD
Trimipramine—Nortriptyline—CYP3A4—breast cancer	2.75e-05	0.0107	CrCbGaD
Trimipramine—HTR2A—endocrine gland—breast cancer	2.73e-05	0.0111	CbGeAlD
Trimipramine—CYP2D6—female gonad—breast cancer	2.67e-05	0.0109	CbGeAlD
Trimipramine—Asthenia—Methotrexate—breast cancer	2.67e-05	0.000239	CcSEcCtD
Trimipramine—Feeling abnormal—Doxorubicin—breast cancer	2.65e-05	0.000237	CcSEcCtD
Trimipramine—Desipramine—CYP2D6—breast cancer	2.64e-05	0.0102	CrCbGaD
Trimipramine—Pruritus—Methotrexate—breast cancer	2.63e-05	0.000235	CcSEcCtD
Trimipramine—Urticaria—Doxorubicin—breast cancer	2.56e-05	0.000229	CcSEcCtD
Trimipramine—ABCB1—endometrium—breast cancer	2.55e-05	0.0104	CbGeAlD
Trimipramine—Abdominal pain—Doxorubicin—breast cancer	2.55e-05	0.000228	CcSEcCtD
Trimipramine—Body temperature increased—Doxorubicin—breast cancer	2.55e-05	0.000228	CcSEcCtD
Trimipramine—Diarrhoea—Methotrexate—breast cancer	2.55e-05	0.000228	CcSEcCtD
Trimipramine—CYP3A4—endocrine gland—breast cancer	2.53e-05	0.0103	CbGeAlD
Trimipramine—Asthenia—Epirubicin—breast cancer	2.5e-05	0.000223	CcSEcCtD
Trimipramine—CYP2D6—endocrine gland—breast cancer	2.49e-05	0.0101	CbGeAlD
Trimipramine—Doxepin—CYP3A4—breast cancer	2.47e-05	0.00957	CrCbGaD
Trimipramine—Pruritus—Epirubicin—breast cancer	2.46e-05	0.00022	CcSEcCtD
Trimipramine—Dizziness—Methotrexate—breast cancer	2.46e-05	0.00022	CcSEcCtD
Trimipramine—Clomipramine—ALB—breast cancer	2.45e-05	0.00952	CrCbGaD
Trimipramine—Methadone—CYP3A4—breast cancer	2.45e-05	0.00952	CrCbGaD
Trimipramine—Orphenadrine—CYP3A4—breast cancer	2.4e-05	0.00933	CrCbGaD
Trimipramine—Nortriptyline—ALB—breast cancer	2.4e-05	0.00931	CrCbGaD
Trimipramine—Diarrhoea—Epirubicin—breast cancer	2.38e-05	0.000213	CcSEcCtD
Trimipramine—Vomiting—Methotrexate—breast cancer	2.37e-05	0.000211	CcSEcCtD
Trimipramine—ABCB1—uterus—breast cancer	2.35e-05	0.00955	CbGeAlD
Trimipramine—Rash—Methotrexate—breast cancer	2.35e-05	0.00021	CcSEcCtD
Trimipramine—Dermatitis—Methotrexate—breast cancer	2.34e-05	0.000209	CcSEcCtD
Trimipramine—Clomipramine—ABCB1—breast cancer	2.34e-05	0.00909	CrCbGaD
Trimipramine—Headache—Methotrexate—breast cancer	2.33e-05	0.000208	CcSEcCtD
Trimipramine—Asthenia—Doxorubicin—breast cancer	2.31e-05	0.000207	CcSEcCtD
Trimipramine—ABCB1—pituitary gland—breast cancer	2.31e-05	0.00937	CbGeAlD
Trimipramine—Dizziness—Epirubicin—breast cancer	2.3e-05	0.000206	CcSEcCtD
Trimipramine—ABCB1—adipose tissue—breast cancer	2.3e-05	0.00934	CbGeAlD
Trimipramine—Pruritus—Doxorubicin—breast cancer	2.28e-05	0.000204	CcSEcCtD
Trimipramine—Desipramine—CYP3A4—breast cancer	2.26e-05	0.00878	CrCbGaD
Trimipramine—HRH1—lymph node—breast cancer	2.26e-05	0.00917	CbGeAlD
Trimipramine—Chlorpromazine—CYP2D6—breast cancer	2.25e-05	0.00873	CrCbGaD
Trimipramine—Imipramine—CYP2D6—breast cancer	2.24e-05	0.00868	CrCbGaD
Trimipramine—Amitriptyline—CYP2D6—breast cancer	2.22e-05	0.00863	CrCbGaD
Trimipramine—ADRA2A—lymph node—breast cancer	2.22e-05	0.00901	CbGeAlD
Trimipramine—Vomiting—Epirubicin—breast cancer	2.21e-05	0.000198	CcSEcCtD
Trimipramine—Nausea—Methotrexate—breast cancer	2.21e-05	0.000198	CcSEcCtD
Trimipramine—Diarrhoea—Doxorubicin—breast cancer	2.2e-05	0.000197	CcSEcCtD
Trimipramine—Rash—Epirubicin—breast cancer	2.2e-05	0.000196	CcSEcCtD
Trimipramine—Dermatitis—Epirubicin—breast cancer	2.19e-05	0.000196	CcSEcCtD
Trimipramine—Promazine—CYP3A4—breast cancer	2.19e-05	0.00851	CrCbGaD
Trimipramine—Headache—Epirubicin—breast cancer	2.18e-05	0.000195	CcSEcCtD
Trimipramine—Dizziness—Doxorubicin—breast cancer	2.13e-05	0.00019	CcSEcCtD
Trimipramine—ABCB1—female reproductive system—breast cancer	2.11e-05	0.00858	CbGeAlD
Trimipramine—Promethazine—ABCB1—breast cancer	2.08e-05	0.00805	CrCbGaD
Trimipramine—Nausea—Epirubicin—breast cancer	2.07e-05	0.000185	CcSEcCtD
Trimipramine—ABCB1—adrenal gland—breast cancer	2.06e-05	0.00837	CbGeAlD
Trimipramine—Doxepin—ABCB1—breast cancer	2.05e-05	0.00797	CrCbGaD
Trimipramine—Vomiting—Doxorubicin—breast cancer	2.05e-05	0.000183	CcSEcCtD
Trimipramine—Methadone—ABCB1—breast cancer	2.04e-05	0.00793	CrCbGaD
Trimipramine—Rash—Doxorubicin—breast cancer	2.03e-05	0.000182	CcSEcCtD
Trimipramine—Dermatitis—Doxorubicin—breast cancer	2.03e-05	0.000181	CcSEcCtD
Trimipramine—Headache—Doxorubicin—breast cancer	2.02e-05	0.00018	CcSEcCtD
Trimipramine—ABCB1—bone marrow—breast cancer	1.99e-05	0.0081	CbGeAlD
Trimipramine—Chlorpromazine—CYP3A4—breast cancer	1.93e-05	0.00749	CrCbGaD
Trimipramine—ABCB1—female gonad—breast cancer	1.92e-05	0.00781	CbGeAlD
Trimipramine—Imipramine—CYP3A4—breast cancer	1.92e-05	0.00745	CrCbGaD
Trimipramine—Nausea—Doxorubicin—breast cancer	1.91e-05	0.000171	CcSEcCtD
Trimipramine—Amitriptyline—CYP3A4—breast cancer	1.91e-05	0.0074	CrCbGaD
Trimipramine—Desipramine—ABCB1—breast cancer	1.88e-05	0.00731	CrCbGaD
Trimipramine—ABCB1—endocrine gland—breast cancer	1.79e-05	0.00726	CbGeAlD
Trimipramine—Chlorpromazine—ALB—breast cancer	1.68e-05	0.00653	CrCbGaD
Trimipramine—Amitriptyline—ALB—breast cancer	1.66e-05	0.00646	CrCbGaD
Trimipramine—Chlorpromazine—ABCB1—breast cancer	1.61e-05	0.00623	CrCbGaD
Trimipramine—Imipramine—ABCB1—breast cancer	1.6e-05	0.0062	CrCbGaD
Trimipramine—Amitriptyline—ABCB1—breast cancer	1.59e-05	0.00616	CrCbGaD
Trimipramine—ABCB1—lymph node—breast cancer	1.24e-05	0.00502	CbGeAlD
Trimipramine—ADRA2A—Signaling Pathways—MDM2—breast cancer	1.29e-06	1.9e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—HRAS—breast cancer	1.29e-06	1.9e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CASP3—breast cancer	1.29e-06	1.9e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL2—breast cancer	1.29e-06	1.9e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MAPK8—breast cancer	1.29e-06	1.9e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—RAF1—breast cancer	1.29e-06	1.9e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—AKT1—breast cancer	1.28e-06	1.89e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—IL6—breast cancer	1.28e-06	1.89e-05	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—AKT1—breast cancer	1.28e-06	1.89e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—RELA—breast cancer	1.28e-06	1.89e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—SRC—breast cancer	1.28e-06	1.89e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—STAT3—breast cancer	1.28e-06	1.89e-05	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—AKT1—breast cancer	1.28e-06	1.89e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CG—breast cancer	1.28e-06	1.88e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—SRC—breast cancer	1.27e-06	1.88e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ERBB2—breast cancer	1.27e-06	1.88e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CASP3—breast cancer	1.27e-06	1.87e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	1.27e-06	1.87e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL2—breast cancer	1.27e-06	1.87e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CASP3—breast cancer	1.27e-06	1.87e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CG—breast cancer	1.27e-06	1.87e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL2—breast cancer	1.27e-06	1.87e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TP53—breast cancer	1.26e-06	1.86e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—IL6—breast cancer	1.26e-06	1.86e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—IL6—breast cancer	1.26e-06	1.86e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCND1—breast cancer	1.26e-06	1.85e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MTOR—breast cancer	1.26e-06	1.85e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PIK3CB—breast cancer	1.26e-06	1.85e-05	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	1.26e-06	1.85e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—JUN—breast cancer	1.25e-06	1.85e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—VEGFA—breast cancer	1.25e-06	1.84e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CTNNB1—breast cancer	1.24e-06	1.83e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CASP3—breast cancer	1.24e-06	1.83e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL2—breast cancer	1.24e-06	1.83e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—VEGFA—breast cancer	1.24e-06	1.83e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCND1—breast cancer	1.24e-06	1.82e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—IL6—breast cancer	1.24e-06	1.82e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—STAT3—breast cancer	1.24e-06	1.82e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—JUN—breast cancer	1.23e-06	1.82e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCND1—breast cancer	1.23e-06	1.82e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—JUN—breast cancer	1.23e-06	1.81e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—COMT—breast cancer	1.23e-06	1.81e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—STAT3—breast cancer	1.23e-06	1.81e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CTNNB1—breast cancer	1.22e-06	1.8e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTP1—breast cancer	1.22e-06	1.8e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MAPK3—breast cancer	1.22e-06	1.8e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CTNNB1—breast cancer	1.22e-06	1.8e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CD—breast cancer	1.22e-06	1.8e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—SRC—breast cancer	1.22e-06	1.8e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MMP9—breast cancer	1.22e-06	1.8e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CDKN1A—breast cancer	1.22e-06	1.79e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PTEN—breast cancer	1.21e-06	1.79e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCND1—breast cancer	1.21e-06	1.78e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—HRAS—breast cancer	1.21e-06	1.78e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—JUN—breast cancer	1.21e-06	1.78e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—HMOX1—breast cancer	1.21e-06	1.78e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CXCL8—breast cancer	1.21e-06	1.78e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—ALB—breast cancer	1.21e-06	1.78e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ITPR1—breast cancer	1.2e-06	1.78e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MMP9—breast cancer	1.2e-06	1.77e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—HRAS—breast cancer	1.2e-06	1.77e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	1.2e-06	1.77e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MMP9—breast cancer	1.2e-06	1.77e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CDKN1A—breast cancer	1.2e-06	1.76e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CDKN1A—breast cancer	1.19e-06	1.76e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PTEN—breast cancer	1.19e-06	1.76e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CD—breast cancer	1.19e-06	1.76e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PTEN—breast cancer	1.19e-06	1.76e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MYC—breast cancer	1.19e-06	1.75e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—VEGFA—breast cancer	1.19e-06	1.75e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MAPK8—breast cancer	1.19e-06	1.75e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TGFB1—breast cancer	1.19e-06	1.75e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—AKT1—breast cancer	1.18e-06	1.74e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MAPK3—breast cancer	1.18e-06	1.74e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CDKN1B—breast cancer	1.18e-06	1.74e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—ALB—breast cancer	1.18e-06	1.73e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—STAT3—breast cancer	1.18e-06	1.73e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MMP9—breast cancer	1.18e-06	1.73e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MAPK3—breast cancer	1.17e-06	1.73e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	1.17e-06	1.73e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PTEN—breast cancer	1.17e-06	1.72e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MAPK8—breast cancer	1.17e-06	1.72e-05	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	1.17e-06	1.72e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MAPK8—breast cancer	1.16e-06	1.72e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—AKT1—breast cancer	1.16e-06	1.72e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—EGFR—breast cancer	1.16e-06	1.71e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—AKT1—breast cancer	1.16e-06	1.71e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ABCB1—breast cancer	1.16e-06	1.71e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IL6—breast cancer	1.16e-06	1.71e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CASP3—breast cancer	1.16e-06	1.7e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL2—breast cancer	1.15e-06	1.7e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—NOS3—breast cancer	1.15e-06	1.7e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—IL6—breast cancer	1.15e-06	1.69e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MYC—breast cancer	1.15e-06	1.69e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TGFB1—breast cancer	1.15e-06	1.69e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	1.14e-06	1.68e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MYC—breast cancer	1.14e-06	1.68e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	1.14e-06	1.68e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TGFB1—breast cancer	1.14e-06	1.68e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—TYMS—breast cancer	1.14e-06	1.68e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—NOS3—breast cancer	1.13e-06	1.66e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.13e-06	1.66e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GSTM1—breast cancer	1.13e-06	1.66e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—NCOR1—breast cancer	1.13e-06	1.66e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCND1—breast cancer	1.12e-06	1.66e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—SRC—breast cancer	1.12e-06	1.66e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MAPK3—breast cancer	1.12e-06	1.66e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.12e-06	1.66e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—EGFR—breast cancer	1.12e-06	1.65e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—JUN—breast cancer	1.12e-06	1.65e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—EGFR—breast cancer	1.12e-06	1.65e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	1.11e-06	1.64e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CD—breast cancer	1.11e-06	1.64e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—ALB—breast cancer	1.11e-06	1.63e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—SRC—breast cancer	1.11e-06	1.63e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—SRC—breast cancer	1.1e-06	1.63e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—ALB—breast cancer	1.1e-06	1.62e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—KRAS—breast cancer	1.1e-06	1.62e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—VEGFA—breast cancer	1.1e-06	1.61e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MYC—breast cancer	1.09e-06	1.61e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MMP9—breast cancer	1.09e-06	1.61e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TGFB1—breast cancer	1.09e-06	1.61e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	1.09e-06	1.6e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PTEN—breast cancer	1.09e-06	1.6e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—STAT3—breast cancer	1.08e-06	1.6e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—SRC—breast cancer	1.08e-06	1.6e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—VEGFA—breast cancer	1.08e-06	1.59e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GPX1—breast cancer	1.08e-06	1.59e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—VEGFA—breast cancer	1.08e-06	1.59e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—EGFR—breast cancer	1.07e-06	1.58e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—AKT1—breast cancer	1.07e-06	1.57e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—STAT3—breast cancer	1.07e-06	1.57e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CYP1A1—breast cancer	1.07e-06	1.57e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—STAT3—breast cancer	1.06e-06	1.57e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CB—breast cancer	1.06e-06	1.57e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	1.06e-06	1.57e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—NOS3—breast cancer	1.06e-06	1.56e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—KRAS—breast cancer	1.06e-06	1.56e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	1.06e-06	1.56e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ERCC2—breast cancer	1.06e-06	1.56e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	1.06e-06	1.56e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—KRAS—breast cancer	1.06e-06	1.56e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTGS2—breast cancer	1.05e-06	1.55e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—NOS3—breast cancer	1.05e-06	1.55e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—STAT3—breast cancer	1.04e-06	1.54e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CB—breast cancer	1.04e-06	1.53e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MAPK3—breast cancer	1.04e-06	1.53e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTGS2—breast cancer	1.03e-06	1.52e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MAPK3—breast cancer	1.02e-06	1.5e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MAPK3—breast cancer	1.02e-06	1.5e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—KRAS—breast cancer	1.01e-06	1.49e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	1.01e-06	1.49e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MYC—breast cancer	1.01e-06	1.49e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SRC—breast cancer	1.01e-06	1.48e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TGFB1—breast cancer	1.01e-06	1.48e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	9.98e-07	1.47e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—MTHFR—breast cancer	9.94e-07	1.47e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MYC—breast cancer	9.92e-07	1.46e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MYC—breast cancer	9.9e-07	1.46e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TGFB1—breast cancer	9.89e-07	1.46e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TGFB1—breast cancer	9.87e-07	1.46e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—EGFR—breast cancer	9.86e-07	1.45e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	9.81e-07	1.45e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CB—breast cancer	9.79e-07	1.44e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TP53—breast cancer	9.77e-07	1.44e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PIK3CA—breast cancer	9.74e-07	1.44e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MYC—breast cancer	9.71e-07	1.43e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—STAT3—breast cancer	9.71e-07	1.43e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CB—breast cancer	9.71e-07	1.43e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTGS2—breast cancer	9.7e-07	1.43e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—EGFR—breast cancer	9.7e-07	1.43e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	9.69e-07	1.43e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	9.69e-07	1.43e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—EGFR—breast cancer	9.68e-07	1.43e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTGS2—breast cancer	9.62e-07	1.42e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—EGFR—breast cancer	9.5e-07	1.4e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TP53—breast cancer	9.43e-07	1.39e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TP53—breast cancer	9.38e-07	1.38e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—HRAS—breast cancer	9.34e-07	1.38e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—KRAS—breast cancer	9.31e-07	1.37e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	9.28e-07	1.37e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	9.28e-07	1.37e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTEN—breast cancer	9.2e-07	1.36e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CAV1—breast cancer	9.17e-07	1.35e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—KRAS—breast cancer	9.16e-07	1.35e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PIK3CA—breast cancer	9.16e-07	1.35e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—KRAS—breast cancer	9.14e-07	1.35e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MYC—breast cancer	9.02e-07	1.33e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—HRAS—breast cancer	9.02e-07	1.33e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	9e-07	1.33e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTEN—breast cancer	8.98e-07	1.32e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TP53—breast cancer	8.98e-07	1.32e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—KRAS—breast cancer	8.97e-07	1.32e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—HRAS—breast cancer	8.97e-07	1.32e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL6—breast cancer	8.94e-07	1.32e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—EGFR—breast cancer	8.82e-07	1.3e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL6—breast cancer	8.63e-07	1.27e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—HRAS—breast cancer	8.59e-07	1.27e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL6—breast cancer	8.58e-07	1.27e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PIK3CA—breast cancer	8.56e-07	1.26e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTEN—breast cancer	8.46e-07	1.25e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PIK3CA—breast cancer	8.42e-07	1.24e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PIK3CA—breast cancer	8.4e-07	1.24e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTEN—breast cancer	8.39e-07	1.24e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CG—breast cancer	8.35e-07	1.23e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—KRAS—breast cancer	8.34e-07	1.23e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TP53—breast cancer	8.28e-07	1.22e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—AKT1—breast cancer	8.25e-07	1.22e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	8.24e-07	1.22e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL6—breast cancer	8.22e-07	1.21e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TP53—breast cancer	8.14e-07	1.2e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TP53—breast cancer	8.13e-07	1.2e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TP53—breast cancer	7.97e-07	1.18e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—AKT1—breast cancer	7.96e-07	1.17e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—AKT1—breast cancer	7.92e-07	1.17e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—HRAS—breast cancer	7.92e-07	1.17e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—HRAS—breast cancer	7.79e-07	1.15e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—HRAS—breast cancer	7.77e-07	1.15e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	7.66e-07	1.13e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HRAS—breast cancer	7.63e-07	1.12e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—AKT1—breast cancer	7.58e-07	1.12e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL6—breast cancer	7.58e-07	1.12e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—AKT1—breast cancer	7.48e-07	1.1e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL6—breast cancer	7.45e-07	1.1e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL6—breast cancer	7.44e-07	1.1e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TP53—breast cancer	7.41e-07	1.09e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CD—breast cancer	7.34e-07	1.08e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL6—breast cancer	7.3e-07	1.08e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ALB—breast cancer	7.25e-07	1.07e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HRAS—breast cancer	7.09e-07	1.04e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—AKT1—breast cancer	6.99e-07	1.03e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—NOS3—breast cancer	6.93e-07	1.02e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—AKT1—breast cancer	6.88e-07	1.01e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—AKT1—breast cancer	6.86e-07	1.01e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL6—breast cancer	6.78e-07	1e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—AKT1—breast cancer	6.73e-07	9.93e-06	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CA—breast cancer	6.49e-07	9.57e-06	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CB—breast cancer	6.4e-07	9.44e-06	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTGS2—breast cancer	6.34e-07	9.35e-06	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CA—breast cancer	6.33e-07	9.34e-06	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—AKT1—breast cancer	6.26e-07	9.22e-06	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CA—breast cancer	5.97e-07	8.8e-06	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CA—breast cancer	5.92e-07	8.72e-06	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTEN—breast cancer	5.53e-07	8.15e-06	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—AKT1—breast cancer	5.3e-07	7.81e-06	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—AKT1—breast cancer	5.17e-07	7.63e-06	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—AKT1—breast cancer	4.88e-07	7.19e-06	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—AKT1—breast cancer	4.83e-07	7.12e-06	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CA—breast cancer	3.9e-07	5.75e-06	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—AKT1—breast cancer	3.19e-07	4.7e-06	CbGpPWpGaD
